U.S. market Closed. Opens in 5 hours 6 minutes

OMCL | Omnicell, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 47.85 - 49.53
52 Week Range 25.12 - 55.75
Beta 0.80
Implied Volatility 104.48%
IV Rank 21.52%
Day's Volume 610,282
Average Volume 521,964
Shares Outstanding 45,993,800
Market Cap 2,231,159,238
Sector Healthcare
Industry Medical - Healthcare Information Services
IPO Date 2001-08-09
Valuation
Profitability
Growth
Health
P/E Ratio -124.38
Forward P/E Ratio N/A
EPS -0.39
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 3,630
Country USA
Website OMCL
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
OMCL's peers: HSTM, NRC, NXGN, FORA, AGTI, MDRX, CPSI, DH, EVH, CMAX, CERT, RCM
*Chart delayed
Analyzing fundamentals for OMCL we got that it has weak fundamentals where Valuation is considered to be fairly valued, Profitability is unacceptably poor, Growth is bad and Health is passable. For more detailed analysis please see OMCL Fundamentals page.

Watching at OMCL technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on OMCL Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙